Jiwon Oh


Scientist, Keenan Research Centre for Biomedical Science

Research Programs


Research Interests

Multiple sclerosis (MS), MRI, spinal cord, clinical trials

Research Activities

I am leading development of the MRI in the MS research program at St. Michael’s Hospital. I am conducting a number of clinical research projects evaluating the use of advanced MRI techniques in the spinal cord in patients with various sub-types of MS.

Recent Publications

  1. Tur, C, Kalincik, T, Oh, J, Sormani, MP, Tintoré, M, Butzkueven, H et al.. Head-to-head drug comparisons in multiple sclerosis: Urgent action needed. Neurology. 2019; :. doi: 10.1212/WNL.0000000000008319. PubMed PMID:31591277 .
  2. Almusalam, N, Oh, J, Terzaghi, M, Maurino, J, Bakdache, F, Montoya, A et al.. Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain. JAMA Netw Open. 2019;2 (7):e197093. doi: 10.1001/jamanetworkopen.2019.7093. PubMed PMID:31314113 PubMed Central PMC6647550.
  3. Saposnik, G, Oh, J, Terzaghi, MA, Kostyrko, P, Bakdache, F, Montoya, A et al.. Emotional expressions associated with therapeutic inertia in multiple sclerosis care. Mult Scler Relat Disord. 2019;34 :17-28. doi: 10.1016/j.msard.2019.05.029. PubMed PMID:31226545 .
  4. Miller, AE, Vermersch, P, Kappos, L, Comi, G, Freedman, MS, Oh, J et al.. Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★. Mult Scler Relat Disord. 2019;33 :131-138. doi: 10.1016/j.msard.2019.05.014. PubMed PMID:31195337 .
  5. Zipp, F, Oh, J, Fragoso, YD, Waubant, E. Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis. Nat Rev Neurol. 2019;15 (8):441-445. doi: 10.1038/s41582-019-0194-0. PubMed PMID:31086264 .
  6. Coyle, PK, Oh, J, Magyari, M, Oreja-Guevara, C, Houtchens, M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Mult Scler Relat Disord. 2019;32 :54-63. doi: 10.1016/j.msard.2019.04.003. PubMed PMID:31030020 .
  7. Oh, J, Ontaneda, D, Azevedo, C, Klawiter, EC, Absinta, M, Arnold, DL et al.. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019;92 (11):519-533. doi: 10.1212/WNL.0000000000007099. PubMed PMID:30787160 PubMed Central PMC6511106.
  8. Schwartz, DL, Tagge, I, Powers, K, Ahn, S, Bakshi, R, Calabresi, PA et al.. Multisite reliability and repeatability of an advanced brain MRI protocol. J Magn Reson Imaging. 2019;50 (3):878-888. doi: 10.1002/jmri.26652. PubMed PMID:30652391 PubMed Central PMC6636359.
  9. Saposnik, G, Montalban, X, Selchen, D, Terzaghi, MA, Bakdache, F, Montoya, A et al.. Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists. Front Neurol. 2018;9 :781. doi: 10.3389/fneur.2018.00781. PubMed PMID:30319523 PubMed Central PMC6165907.
  10. Caldito, NG, Saidha, S, Sotirchos, ES, Dewey, BE, Cowley, NJ, Glaister, J et al.. Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study. Brain. 2018;141 (11):3115-3129. doi: 10.1093/brain/awy245. PubMed PMID:30312381 PubMed Central PMC6202573.
Search PubMed

Affiliations & Other Activities

  • Staff Neurologist, Division of Neurology, Department of Medicine, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto
  • Assistant Professor, Department of Neurology, Johns Hopkins University